Skip to main content

PulseHaler™: A Novel Treatment Device for COPD.

Project description

New solution brings relief to chronic lung disease sufferers

The EU-funded STOP-COPD project has developed a novel device, called PulseHaler™, to treat chronic obstructive pulmonary disease (COPD), a progressive disease of the lungs. The device successfully opens the small airways, which are known to collapse in COPD patients, making it difficult for them to breathe. PulseHaler™ improves the exercise capacity, reduces breathlessness, and improves quality of life of COPD sufferers. Researchers will optimise the device with new features and functions and prepare it for large-scale manufacturing. Given the millions of COPD patients in Europe alone, the device has the potential to substantially reduce associated healthcare costs.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Coordinator

RESPINOVA LTD
Net EU contribution
€ 2 414 365,63
Address
8 Hachoshlim St.
4672408 Herzliya Pituach
Israel

See on map

Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 1 034 728,12